The president said that the raw materials are being shipped by air and are on schedule to begin test runs for the production of several generic pharmaceuticals by the end of May.
African Global Pharma will then proceed to produce a variety of generic medicines. There are thirteen different medicines slated to begin production with a further eighteen to be registered as production capacity is expanded.
Mr Keks is currently in Africa and will continue to oversee and report on the continued progress in the Sunyani, Ghana manufacturing facilities.
Emerging World Pharma is an investor in generic based pharmaceutical companies manufacturing within developing nations. The company focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. Market research shows that these branches are the most secure, protected and reputable for the distribution of medicines.